Authors


Marc G. Sturgill, PharmD

Latest:

Irritable Bowel Syndrome: Helping Patients Access Appropriate Treatment in an Era of Investigation and Discovery

This Continuing Education activity is supported by an independent educational grant from Allergan Inc. and Prometheus Laboratories, Inc.


Winston Wong, PharmD

Latest:

The Pharmacist’s Role in Maximizing HIV Antiretroviral Therapy

Through ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.


Xiaolan Ye, PhD

Latest:

Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and Costs

Real-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.


Marile L. Santamarina, MS, PharmD

Latest:

ABCs of Avoiding Microvascular Comorbidities of Diabetes

Dr. Santamarina is an assistant professor of pharmacy practice at Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, West Palm Beach, Fla.


Miranda Wilhelm, PharmD

Latest:

Ensuring Health Equity in Vaccination Access: How Pharmacies Can Work With Community Organizations

Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.



Sadaf Emad-Vaez, PharmD Candidate

Latest:

Use of Multiple Sclerosis Disease-Modifying Therapies During COVID-19 Pandemic

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.




Alon Yehoshua, PharmD, MS

Latest:

Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder Interventions

This cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.



Benyam Muluneh, PharmD, CPP

Latest:

Metastatic Breast Cancer Updates

Incremental gains in survival and new targeted agents in the pipeline offer promise.






Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP

Latest:

Cannabidiol Gets Thumbs Up from Federal Agencies

The FDA approved cannabidiol (CBD) last year for the treatment of seizures associated with Lennox-Gastaut and Dravet syndromes in patients aged 2 years and older. As pharmacists, we will likely be called upon as experts in CBD therapeutics.


Yunlu Chen, PharmD Candidate

Latest:

Through Thick and Thin: Using Anticlotting Drugs

Helping patients understand their regimen can boost adherence.



Hélène Parisé, MA

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.



Meghana Aruru, MBA, PhD (Cand)

Latest:

Examining Part D Beneficiaries' Medication Use in the Doughnut Hole

The authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.



Jamie Paek, PharmD

Latest:

Challenges, Opportunities Mark Health Care Landscape in 2022

Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend


Steve Dudley, PharmD, DABAT

Latest:

Poison Control Centers Offer Unique Opportunities for Pharmacists

More than $45 million in health care expenditures is prevented, and that money saved, annually by Arizona’s 2 poison control centers. But what do they do?



Joseph Cremaldi, PhD

Latest:

A Predictive Modeling Primer for Specialty Pharmacy

As the industry focuses more on value-based care, predictive modeling allows pharmacies to shift their services from a one-size-fits-all approach to a personalized, high-touch strategy.


Caitlin Turnbull, PharmD candidate

Latest:

The Implications of Antibiotic Overuse Warrant Attention to Guidelines

Up to half of antibiotics prescribed in the United States may be unnecessary, leading to avoidable adverse events and development of antibiotic resistance and attendant costs.


Sean Swisher, PharmD, RPIC

Latest:

Current Tech Hurdles in Specialty Pharmacy Lead to a Decrease in Effective Care

Lost within the fast-paced specialty pharmacy environment are updates to pharmacy software systems that can accommodate the ever-growing needs of patients.


Saro Arakelians, PharmD

Latest:

Pancreatic Cancer Has a Growing Array of Treatment Options

However, early diagnosis still presents challenges and limits treatment options.